Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Blocking HIV replication by targeting Tat protein.

F Hamy1, N Gelus, M Zeller

  • 1Novartis Pharma Research, Basel, Switzerland.

Chemistry & Biology
|September 12, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect on bone mineralization of continued growth hormone therapy at the transition between childhood and adulthood.

Endocrine connections·2026
Same author

High performance recycled CFRP composites based on reused carbon fabrics through sustainable mild solvolysis route.

Scientific reports·2022
Same author

Uranium retention in a Callovo-Oxfordian clay rock formation: From laboratory-based models to in natura conditions.

Chemosphere·2022
Same author

Femoral fracture during breech vaginal delivery: A case report.

Journal of gynecology obstetrics and human reproduction·2022
Same author

Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study.

European journal of nuclear medicine and molecular imaging·2020
Same author

Role of family history and clinical screening in the identification of families with idiopathic dilated cardiomyopathy in Johannesburg, South Africa.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2019
Same journal

The Hedgehog Pathway Effector Smoothened Exhibits Signaling Competency in the Absence of Ciliary Accumulation.

Chemistry & biology·2017
Same journal

DIVERSE System: De Novo Creation of Peptide Tags for Non-enzymatic Covalent Labeling by In Vitro Evolution for Protein Imaging Inside Living Cells.

Chemistry & biology·2015
Same journal

Differential Regulation of Specific Sphingolipids in Colon Cancer Cells during Staurosporine-Induced Apoptosis.

Chemistry & biology·2015
Same journal

Synthetic Peptides as cGMP-Independent Activators of cGMP-Dependent Protein Kinase Iα.

Chemistry & biology·2015
Same journal

Unraveling the B. pseudomallei Heptokinase WcbL: From Structure to Drug Discovery.

Chemistry & biology·2015
Same journal

Vitamin C as Cancer Destroyer, Investigating Sulfhydration, and the Variability in CFTR Interactome.

Chemistry & biology·2015
See all related articles

Researchers discovered a novel compound, CGA137053, that targets HIV Tat protein. This dual-action drug inhibits viral gene regulation and coreceptor upregulation, offering a promising new HIV treatment strategy.

Area of Science:

  • Virology
  • Drug Discovery
  • Molecular Biology

Background:

  • Viral drug resistance impedes HIV treatment development.
  • Novel therapeutic targets are crucial for combating HIV.

Purpose of the Study:

  • To identify new compounds and targets for HIV drug development.
  • To explore alternative strategies beyond traditional viral targets.

Main Methods:

  • Investigated the Tat-driven process of HIV gene regulation.
  • Utilized structure, molecular modeling, and dynamics.
  • Assessed compound activity on HIV-infected primary human cells.

Main Results:

  • Discovered a new class of compounds targeting HIV Tat protein.

Related Experiment Videos

  • Identified stilbene derivative CGA137053 as a novel Tat antagonist.
  • CGA137053 inhibits Tat/TAR complexation without binding nucleic acids.

    • Conclusions:

    • CGA137053 directly binds Tat protein, not TAR RNA.
    • Compound antagonizes TAR-independent Tat activity, preventing CXCR4 upregulation.
    • CGA137053 is a potent, double-hitting Tat antagonist with high specificity and low cytotoxicity.